At Novartis, Partnering is at the core of our business: we collaborate to unlock the potential of cutting-edge science and advance patient care. From our focused R&D engine to high-quality manufacturing and novel access approaches, we have the expertise and capabilities to bring high-value treatments to millions of patients worldwide.
As a company focused on innovative medicines, we work across four therapeutic areas and five technology platforms: Oncology, Cardio, Renal, and Metabolism, Immunology, Neuroscience and Discovery Platforms & AI, including Chemistry, Biotherapeutics, xRNA, Radioligand therapy, and Gene and Cell therapy.
Log in to BIO Partnering™ to send us a meeting request.
Susanne Kreutz
Global Head Corporate & Business Development
"In partnering, there is no 'one-size-fits-all,' and our teams are agile and flexible, approaching deal-making in a deal-type agnostic manner. This enables us to tailor each deal to its unique circumstances, aiming at delivering high-value treatments to millions of patients worldwide."
CORPORATE & BUSINESS DEVELOPMENT LEADERSHIP TEAM
Paul Thibodeau
Global Head Search & Evaluation
Guillaume Vignon
Global Head BD&L Transactions
Arun Bisht
Head C&BD Excellence and Operations
CORPORATE & BUSINESS DEVELOPMENT TEAM
